 Laurel Messer
Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin Infusion Systems | 55 | 2026 | 480 | 9.880 |
Why?
| | Diabetes Mellitus, Type 1 | 78 | 2026 | 3922 | 7.440 |
Why?
| | Blood Glucose Self-Monitoring | 45 | 2026 | 701 | 5.040 |
Why?
| | Hypoglycemic Agents | 49 | 2026 | 1399 | 5.040 |
Why?
| | Insulin | 53 | 2026 | 2512 | 5.000 |
Why?
| | Diabetes Mellitus | 13 | 2025 | 1097 | 3.560 |
Why?
| | Blood Glucose | 59 | 2026 | 2341 | 3.360 |
Why?
| | Pancreas, Artificial | 14 | 2021 | 97 | 3.170 |
Why?
| | Hypoglycemia | 19 | 2026 | 479 | 2.470 |
Why?
| | Self-Management | 5 | 2026 | 202 | 1.850 |
Why?
| | Biomedical Technology | 3 | 2020 | 50 | 1.270 |
Why?
| | Diabetes Mellitus, Type 2 | 7 | 2026 | 2588 | 1.180 |
Why?
| | Hyperglycemia | 11 | 2022 | 379 | 1.140 |
Why?
| | Health Plan Implementation | 2 | 2020 | 141 | 1.100 |
Why?
| | Awareness | 2 | 2026 | 110 | 0.930 |
Why?
| | Adolescent | 51 | 2026 | 22530 | 0.920 |
Why?
| | Patient Education as Topic | 5 | 2021 | 777 | 0.920 |
Why?
| | Insulin, Regular, Human | 6 | 2023 | 47 | 0.850 |
Why?
| | Technology | 3 | 2023 | 97 | 0.840 |
Why?
| | Humans | 97 | 2026 | 145475 | 0.830 |
Why?
| | Patient Compliance | 3 | 2020 | 587 | 0.820 |
Why?
| | Health Personnel | 4 | 2025 | 754 | 0.750 |
Why?
| | Mobile Applications | 2 | 2023 | 199 | 0.670 |
Why?
| | Attitude | 2 | 2020 | 259 | 0.630 |
Why?
| | Young Adult | 30 | 2026 | 14219 | 0.610 |
Why?
| | Patient Dropouts | 1 | 2020 | 65 | 0.590 |
Why?
| | Personal Satisfaction | 2 | 2021 | 219 | 0.590 |
Why?
| | Quality of Life | 6 | 2024 | 3204 | 0.590 |
Why?
| | Self Efficacy | 2 | 2021 | 410 | 0.580 |
Why?
| | School Nursing | 1 | 2019 | 33 | 0.570 |
Why?
| | Eczema | 1 | 2018 | 66 | 0.530 |
Why?
| | Adult | 37 | 2026 | 40777 | 0.490 |
Why?
| | Patient Reported Outcome Measures | 4 | 2024 | 497 | 0.480 |
Why?
| | School Health Services | 1 | 2019 | 221 | 0.480 |
Why?
| | Infusions, Subcutaneous | 1 | 2016 | 23 | 0.470 |
Why?
| | Child | 33 | 2024 | 22707 | 0.470 |
Why?
| | Algorithms | 9 | 2026 | 1845 | 0.460 |
Why?
| | Male | 44 | 2026 | 72843 | 0.440 |
Why?
| | Female | 47 | 2026 | 78845 | 0.440 |
Why?
| | Skin | 2 | 2018 | 753 | 0.410 |
Why?
| | Health Behavior | 1 | 2019 | 789 | 0.400 |
Why?
| | Monitoring, Ambulatory | 3 | 2020 | 89 | 0.380 |
Why?
| | Insulin Lispro | 2 | 2022 | 42 | 0.370 |
Why?
| | Patient Satisfaction | 3 | 2023 | 709 | 0.370 |
Why?
| | Insulin Aspart | 2 | 2022 | 30 | 0.370 |
Why?
| | Telemedicine | 1 | 2022 | 961 | 0.360 |
Why?
| | Curriculum | 1 | 2019 | 1070 | 0.360 |
Why?
| | Clinical Competence | 1 | 2019 | 1243 | 0.330 |
Why?
| | Glucose | 5 | 2023 | 1048 | 0.290 |
Why?
| | Insulin-Secreting Cells | 2 | 2023 | 392 | 0.280 |
Why?
| | Skiing | 2 | 2019 | 49 | 0.260 |
Why?
| | Surveys and Questionnaires | 6 | 2023 | 6066 | 0.250 |
Why?
| | Meals | 2 | 2018 | 130 | 0.240 |
Why?
| | Exercise | 6 | 2020 | 2198 | 0.240 |
Why?
| | Bionics | 2 | 2022 | 14 | 0.230 |
Why?
| | Follow-Up Studies | 5 | 2023 | 5423 | 0.230 |
Why?
| | Prospective Studies | 6 | 2023 | 8057 | 0.220 |
Why?
| | Retrospective Studies | 8 | 2026 | 17291 | 0.210 |
Why?
| | Dermatitis, Contact | 1 | 2023 | 18 | 0.200 |
Why?
| | Calibration | 3 | 2019 | 152 | 0.190 |
Why?
| | Diabetic Ketoacidosis | 2 | 2023 | 209 | 0.190 |
Why?
| | Feasibility Studies | 3 | 2024 | 1111 | 0.190 |
Why?
| | Smartphone | 1 | 2023 | 106 | 0.180 |
Why?
| | Program Evaluation | 3 | 2021 | 943 | 0.180 |
Why?
| | Middle Aged | 14 | 2026 | 36215 | 0.170 |
Why?
| | Adipose Tissue | 2 | 2016 | 645 | 0.170 |
Why?
| | Pancreas | 1 | 2022 | 341 | 0.150 |
Why?
| | Nursing Theory | 1 | 2019 | 9 | 0.150 |
Why?
| | Sports | 2 | 2019 | 211 | 0.150 |
Why?
| | Vaginal Smears | 1 | 1999 | 54 | 0.150 |
Why?
| | Pilot Projects | 2 | 2019 | 1891 | 0.140 |
Why?
| | Models, Educational | 1 | 2019 | 90 | 0.140 |
Why?
| | Activities of Daily Living | 3 | 2017 | 444 | 0.140 |
Why?
| | Lichen Sclerosus et Atrophicus | 1 | 2018 | 4 | 0.140 |
Why?
| | Genital Diseases, Male | 1 | 2018 | 16 | 0.140 |
Why?
| | Patient Acceptance of Health Care | 1 | 2025 | 881 | 0.140 |
Why?
| | Genital Diseases, Female | 1 | 2018 | 31 | 0.140 |
Why?
| | Wireless Technology | 1 | 2017 | 18 | 0.130 |
Why?
| | Intention | 1 | 2019 | 186 | 0.130 |
Why?
| | Delphi Technique | 1 | 2019 | 332 | 0.130 |
Why?
| | Scleroderma, Systemic | 1 | 2018 | 123 | 0.130 |
Why?
| | Adolescent Nutritional Physiological Phenomena | 1 | 2017 | 29 | 0.130 |
Why?
| | Costs and Cost Analysis | 1 | 2017 | 221 | 0.120 |
Why?
| | Clinical Alarms | 1 | 2016 | 11 | 0.120 |
Why?
| | Emotions | 2 | 2023 | 574 | 0.120 |
Why?
| | Subcutaneous Tissue | 1 | 2016 | 26 | 0.120 |
Why?
| | Pediatrics | 1 | 2024 | 1121 | 0.120 |
Why?
| | Health Education | 1 | 1999 | 346 | 0.120 |
Why?
| | Infusion Pumps, Implantable | 1 | 2016 | 26 | 0.120 |
Why?
| | Ketones | 1 | 2016 | 50 | 0.120 |
Why?
| | Self Concept | 1 | 2017 | 253 | 0.120 |
Why?
| | Healthcare Disparities | 1 | 2023 | 735 | 0.120 |
Why?
| | Decision Support Systems, Clinical | 1 | 2020 | 272 | 0.110 |
Why?
| | Suicide | 1 | 2023 | 728 | 0.110 |
Why?
| | Cost of Illness | 1 | 2017 | 324 | 0.110 |
Why?
| | User-Computer Interface | 1 | 2016 | 165 | 0.110 |
Why?
| | Child, Preschool | 6 | 2022 | 11853 | 0.110 |
Why?
| | Adolescent Behavior | 2 | 2017 | 494 | 0.110 |
Why?
| | Colorado | 4 | 2019 | 4554 | 0.110 |
Why?
| | Quality Improvement | 2 | 2021 | 1295 | 0.110 |
Why?
| | Attitude of Health Personnel | 1 | 2023 | 1193 | 0.110 |
Why?
| | Anxiety | 2 | 2023 | 1118 | 0.110 |
Why?
| | Interpersonal Relations | 1 | 2017 | 397 | 0.110 |
Why?
| | Fear | 1 | 2017 | 368 | 0.100 |
Why?
| | Indians, North American | 1 | 1999 | 597 | 0.100 |
Why?
| | Patient Participation | 1 | 2017 | 439 | 0.100 |
Why?
| | Sleep Wake Disorders | 1 | 2017 | 314 | 0.100 |
Why?
| | Depression | 1 | 2023 | 1546 | 0.100 |
Why?
| | Acetaminophen | 1 | 2015 | 267 | 0.090 |
Why?
| | C-Peptide | 2 | 2023 | 190 | 0.090 |
Why?
| | Precision Medicine | 1 | 2016 | 459 | 0.090 |
Why?
| | Consensus | 2 | 2024 | 477 | 0.090 |
Why?
| | Age Factors | 2 | 2016 | 3342 | 0.090 |
Why?
| | Parents | 2 | 2021 | 1403 | 0.090 |
Why?
| | Cohort Studies | 3 | 2017 | 6013 | 0.080 |
Why?
| | Terbutaline | 1 | 2010 | 7 | 0.080 |
Why?
| | Mass Screening | 1 | 1999 | 1360 | 0.080 |
Why?
| | Circadian Rhythm | 1 | 2015 | 512 | 0.080 |
Why?
| | United States | 6 | 2026 | 16098 | 0.080 |
Why?
| | Aged | 5 | 2026 | 26153 | 0.080 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5905 | 0.080 |
Why?
| | Registries | 1 | 2019 | 2406 | 0.080 |
Why?
| | Seasons | 3 | 2019 | 538 | 0.080 |
Why?
| | Self Care | 2 | 2010 | 390 | 0.070 |
Why?
| | Cross-Over Studies | 3 | 2019 | 608 | 0.070 |
Why?
| | Sleep | 1 | 2016 | 888 | 0.070 |
Why?
| | Amyloid | 1 | 2009 | 94 | 0.070 |
Why?
| | Double-Blind Method | 2 | 2023 | 2062 | 0.070 |
Why?
| | Eating | 1 | 2009 | 387 | 0.060 |
Why?
| | Cold Temperature | 2 | 2019 | 206 | 0.060 |
Why?
| | Age of Onset | 2 | 2022 | 555 | 0.060 |
Why?
| | Snacks | 2 | 2017 | 22 | 0.060 |
Why?
| | Teaching | 1 | 2009 | 237 | 0.060 |
Why?
| | Equipment Failure | 2 | 2016 | 115 | 0.060 |
Why?
| | Quality-Adjusted Life Years | 1 | 2026 | 123 | 0.060 |
Why?
| | Hypertrophy | 2 | 2016 | 128 | 0.060 |
Why?
| | Outpatients | 2 | 2021 | 447 | 0.050 |
Why?
| | Family | 1 | 2009 | 682 | 0.050 |
Why?
| | Treatment Outcome | 4 | 2019 | 11772 | 0.050 |
Why?
| | Verapamil | 1 | 2023 | 37 | 0.050 |
Why?
| | Cost-Benefit Analysis | 1 | 2026 | 639 | 0.050 |
Why?
| | Quality Indicators, Health Care | 1 | 2025 | 336 | 0.050 |
Why?
| | Area Under Curve | 2 | 2016 | 331 | 0.050 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2023 | 1419 | 0.050 |
Why?
| | North Carolina | 2 | 1999 | 129 | 0.050 |
Why?
| | Hospitalization | 2 | 2025 | 2460 | 0.040 |
Why?
| | Self-Injurious Behavior | 1 | 2023 | 141 | 0.040 |
Why?
| | Volunteers | 1 | 1999 | 39 | 0.040 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2019 | 74 | 0.040 |
Why?
| | Community-Institutional Relations | 1 | 1999 | 100 | 0.040 |
Why?
| | Health Status | 1 | 2024 | 832 | 0.040 |
Why?
| | France | 1 | 2018 | 40 | 0.030 |
Why?
| | Societies, Medical | 1 | 2022 | 899 | 0.030 |
Why?
| | Drug Administration Schedule | 2 | 2010 | 782 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2019 | 200 | 0.030 |
Why?
| | Sensitivity and Specificity | 2 | 2016 | 1997 | 0.030 |
Why?
| | Virginia | 1 | 2017 | 57 | 0.030 |
Why?
| | Equipment Design | 1 | 2019 | 525 | 0.030 |
Why?
| | Suicidal Ideation | 1 | 2023 | 580 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2023 | 1747 | 0.030 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2017 | 106 | 0.030 |
Why?
| | Accelerometry | 1 | 2017 | 118 | 0.030 |
Why?
| | Ambulatory Care Facilities | 1 | 2019 | 269 | 0.030 |
Why?
| | Drug Dosage Calculations | 1 | 2016 | 27 | 0.030 |
Why?
| | Artificial Intelligence | 1 | 2021 | 381 | 0.030 |
Why?
| | Body Mass Index | 2 | 2017 | 2445 | 0.030 |
Why?
| | Food Preferences | 1 | 2017 | 126 | 0.030 |
Why?
| | Materials Testing | 1 | 2017 | 345 | 0.030 |
Why?
| | Child Behavior | 1 | 2017 | 236 | 0.030 |
Why?
| | Risk | 1 | 2017 | 919 | 0.030 |
Why?
| | ROC Curve | 1 | 2016 | 617 | 0.030 |
Why?
| | United States Food and Drug Administration | 1 | 2015 | 208 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1266 | 0.030 |
Why?
| | Practice Patterns, Physicians' | 1 | 2022 | 1371 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2025 | 2381 | 0.020 |
Why?
| | Patient Care Team | 1 | 2019 | 696 | 0.020 |
Why?
| | Drug Monitoring | 1 | 2016 | 401 | 0.020 |
Why?
| | Prognosis | 1 | 2020 | 4316 | 0.020 |
Why?
| | Age Distribution | 1 | 2012 | 403 | 0.020 |
Why?
| | Smoking | 1 | 1998 | 1472 | 0.020 |
Why?
| | Prevalence | 1 | 2018 | 2865 | 0.020 |
Why?
| | Glycosuria | 1 | 2009 | 10 | 0.020 |
Why?
| | Islet Amyloid Polypeptide | 1 | 2009 | 48 | 0.020 |
Why?
| | Dietary Carbohydrates | 1 | 2009 | 147 | 0.020 |
Why?
| | Postprandial Period | 1 | 2009 | 114 | 0.020 |
Why?
| | Sex Factors | 1 | 2015 | 2105 | 0.020 |
Why?
| | Least-Squares Analysis | 1 | 2007 | 73 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 8333 | 0.010 |
Why?
| | Body Weight | 1 | 2009 | 971 | 0.010 |
Why?
| | Risk Factors | 2 | 2015 | 10885 | 0.010 |
Why?
| | Imitative Behavior | 1 | 1998 | 4 | 0.010 |
Why?
| | Time Factors | 1 | 2009 | 7123 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2007 | 3413 | 0.010 |
Why?
| | Socialization | 1 | 1998 | 23 | 0.010 |
Why?
| | Internal-External Control | 1 | 1998 | 74 | 0.010 |
Why?
| | Social Adjustment | 1 | 1998 | 64 | 0.010 |
Why?
| | Infant | 1 | 2012 | 10077 | 0.010 |
Why?
| | Smoking Prevention | 1 | 1998 | 166 | 0.010 |
Why?
| | Peer Group | 1 | 1998 | 253 | 0.010 |
Why?
| | Parenting | 1 | 1998 | 319 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 1998 | 2953 | 0.010 |
Why?
|
|
Messer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|